Company Filing History:
Years Active: 2012-2013
Title: Thilo Berkenbusch: Innovator in Hepatitis C Treatment
Introduction
Thilo Berkenbusch is a notable inventor based in Worms, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
One of Thilo's latest patents involves the development of novel crystalline forms of a potent HCV inhibitor. This invention relates to the preparation of these crystalline forms, including the sodium salt thereof, and their pharmaceutical compositions. The methods outlined in this patent aim to enhance the treatment options available for Hepatitis C Viral (HCV) infection.
Career Highlights
Thilo Berkenbusch is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work there focuses on innovative solutions for complex health issues, particularly in viral infections.
Collaborations
Throughout his career, Thilo has collaborated with esteemed colleagues such as Carl Alan Busacca and Burkhard Jaeger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thilo Berkenbusch's contributions to the field of Hepatitis C treatment through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.